Differential effects of paraoxonase 1 (PON1) polymorphisms on cancer risk: evidence from 25 published studies (Q39654131)

13 September 2017

0 references

Differential effects of paraoxonase 1 (PON1) polymorphisms on cancer risk: evidence from 25 published studies (English)

1 reference

13 September 2017

Dai-Hua Fang

1

1 reference

13 September 2017

Cong-Hai Fan

2

1 reference

13 September 2017

Qiang Ji

3

1 reference

13 September 2017

Bo-Xiang Qi

4

1 reference

13 September 2017

Juan Li

5

1 reference

13 September 2017

Lu Wang

6

1 reference

13 September 2017

10 February 2012

1 reference

Molecular Biology Reports

13 September 2017

1 reference

13 September 2017

39

1 reference

13 September 2017

6

1 reference

13 September 2017

6801-6809

1 reference

https://scigraph.springernature.com/pub.10.1007/s11033-012-1505-3

13 September 2017

0 references

cites work

Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain).

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

The role of oxidative stress in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

The molecular basis of the human serum paraoxonase activity polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

Genetic polymorphisms in the Paraoxonase 1 gene and risk of ovarian epithelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

Risk of brain tumors in children and susceptibility to organophosphorus insecticides: the potential role of paraoxonase (PON1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

Association of CYP17, GSTP1, and PON1 polymorphisms with the risk of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

Cost-effectiveness of streptokinase for acute myocardial infarction: A combined meta-analysis and decision analysis of the effects of infarct location and of likelihood of infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

Quantitative synthesis in systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

Investigating paraoxonase-1 gene Q192R and L55M polymorphism in patients with renal cell cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

Oxidative response gene polymorphisms and risk of adult brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

Association of L55M and Q192R polymorphisms in paraoxonase 1 (PON1) gene with breast cancer risk and their clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

Association between xenobiotic gene polymorphisms and non-Hodgkin's lymphoma risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

Free radicals, antioxidant enzymes, and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

Serum paraoxonase activity and oxidative DNA damage in patients with laryngeal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

The choice of a genetic model in the meta-analysis of molecular association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

Oxidants and antioxidants in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

Oxidized LDL, serum oxidizability and serum lipid levels in patients with breast or ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1505-3

Body mass, polymorphisms in obesity-related genes, and the risk of developing breast cancer among women with benign breast disease

21 January 2018

1 reference

12 December 2020

Paraoxonase 1 192 and 55 polymorphisms in osteosarcoma

1 reference

12 December 2020

Systematic reviews on rehabilitation interventions

1 reference

12 December 2020

Investigation of PON1 192 and PON1 55 polymorphisms in ovarian cancer patients in Turkish population.

1 reference

12 December 2020

Xenobiotic gene polymorphisms and susceptibility to multiple myeloma.

1 reference

12 December 2020

Two alleles of the human paraoxonase gene produce different amounts of mRNA. An explanation for differences in serum concentrations of paraoxonase associated with the (Leu-Met54) polymorphism

1 reference

12 December 2020

192R allele of paraoxanase 1 (PON1) gene as a new marker for susceptibility to bladder cancer

1 reference

12 December 2020

Paraoxonase 1 mutations in a Turkish population

1 reference

12 December 2020

Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population

1 reference

12 December 2020

Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations.

1 reference

12 December 2020

Paraoxonase-1 192/55 polymorphisms and the risk of lung cancer in a Turkish population.

1 reference

12 December 2020

Effects of oxidative DNA damage induced by polycyclic aromatic hydrocarbons and genetic polymorphism of the paraoxonase-1 (PON1) gene on lung cancer

1 reference

12 December 2020

Paraoxonase 1 (PON1) polymorphisms and prostate cancer in the CPS-II Nutrition Cohort

1 reference

12 December 2020

Serum paraoxonase levels in pancreatic cancer.

1 reference

12 December 2020

Serum paraoxonase levels in gastric cancer.

1 reference

12 December 2020

10.1007/S11033-012-1505-3

Identifiers

DOI

1 reference

13 September 2017

1 reference